Treatment Reduces Diabetes Risk in People With Rheumatoid Arthritis

From the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), February 2008.

"Antirheumatic, Antimalarial Treatment Reduces Diabetes Risk in People With Rheumatoid Arthritis":

Researchers partly funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) recently found that hydroxychloroquine, a medication used to treat rheumatic diseases and malaria, reduced the incidence of diabetes in people with rheumatoid arthritis (RA). RA is an inflammatory disease that causes pain, swelling, stiffness and loss of function in the joints.

For the full article, see http://www.niams.nih.gov/News_and_Events/Spotlight_on_Research/2008/Diabetes_RA.asp

bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark bookmark

Related posts

Print This Post Print This Post Email This Post Email This Post


Leave your comments

Enter Your Details:




You may use the following markup in your comments:

<a href=""></a> <strong></strong> <em></em> <blockquote></blockquote>

Enter Your Comments:

|Top | Content|

  • Running Time

    From February 1, 2008 to December 2, 2008

  • Carbon Footprint

    CountPagesCarbon
    Words:118783182.51.37g
    Images:80.200.00g
    Total:182.71.37g
    Powered by WordPress Carbon Footprint

|Top | FarBar|



Attention: This is the end of the usable page!
The images below are preloaded standbys only.
This is helpful to those with slower Internet connections.